INNATE PHARMA SP.ADR/1 Financial Flexibility Index
INNATE PHARMA SP.ADR/1 financial flexibility index. INNATE PHARMA SP.ADR/1 (IDDA) has a Financial Flexibility Index of -0.36x as of December 2025. Free cash flow of €-30.21 Million (operating CF €-32.56 Million minus capex €2.35 Million) represents 0% of total liabilities (€84.42 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of INNATE PHARMA SP.ADR/1 (2021–2025)
Financial flexibility index of INNATE PHARMA SP.ADR/1 from 2021 to 2025. Historical Financial Flexibility Index trend for INNATE PHARMA SP.ADR/1 across 5 annual periods. Explore IDDA cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
INNATE PHARMA SP.ADR/1 Financial Flexibility Index by Year (2021–2025)
INNATE PHARMA SP.ADR/1 financial flexibility index by year from 2021 to 2025. Year-by-year free cash flow to debt coverage for INNATE PHARMA SP.ADR/1. For the full cash flow conversion analysis, see cash flow conversion of INNATE PHARMA SP.ADR/1.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.36x | €-30.21 Million | €-32.56 Million | €84.42 Million | ▼ -462.3% |
| 2024 | -0.06x | €-6.50 Million | €-6.90 Million | €102.22 Million | ▲ +74.0% |
| 2023 | -0.25x | €-30.21 Million | €-32.56 Million | €123.29 Million | ▼ -97.2% |
| 2022 | -0.12x | €-18.03 Million | €-19.16 Million | €145.14 Million | ▲ +65.2% |
| 2021 | -0.36x | €-57.13 Million | €-58.46 Million | €160.06 Million | — |